QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9E1B4939F78E3E99513BEFDCAAEE7BF;jsessionid=0D3DBCFC8B84ADDE75E42324D8084A8D;jsessionid=3EFD0032CB15AA01F0040163408157F0;jsessionid=7D16C35F2459D7EAE6FAF343D45E87E2;jsessionid=3167845A0E3768D7575D02765CB82CA8;jsessionid=8CF063BC1B746A0E7DD85BD20B755A4A;jsessionid=2AF3BA0573DA18F14024CF6C062E9995;jsessionid=43BF91C891D8300117245FFD6691A4C0;jsessionid=2B4696CDCC08569676929450B3915FB2;jsessionid=27A6E8E7948C17C917AFECF632EA9D91 (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=31FD067A41084A84C97BE51309D7990D;jsessionid=239C40B3727C3880B4DD59FDA993EB74;jsessionid=12274BD3F00DF96945107322433EFB2D;jsessionid=BABECBC0925C4C2EF20C533A8061A2D4;jsessionid=A9E1B4939F78E3E99513BEFDCAAEE7BF;jsessionid=0D3DBCFC8B84ADDE75E42324D8084A8D;jsessionid=3EFD0032CB15AA01F0040163408157F0;jsessionid=7D16C35F2459D7EAE6FAF343D45E87E2;jsessionid=3167845A0E3768D7575D02765CB82CA8;jsessionid=8CF063BC1B746A0E7DD85BD20B755A4A;jsessionid=2AF3BA0573DA18F14024CF6C062E9995;jsessionid=43BF91C891D8300117245FFD6691A4C0;jsessionid=2B4696CDCC08569676929450B3915FB2;jsessionid=27A6E8E7948C17C917AFECF632EA9D91